Latest News View All
Featured Interview: Scaling Success
How WuXi AppTec Aims to Catalyze Europe’s Biotech Transformation. In an exclusive interview, Dr. Steve Yang, co-CEO of WuXi AppTec, shares insights on strengthening Europe’s...
Continue ReadingFeatured Interview: The End of the Undruggable
Targeted protein degradation (TPD) therapy is a promising new class of targeted treatments to combat cancers and other conditions. In a recent feature by STAT,...
Continue ReadingIntroducing WuXi AppTec’s NMR-based FBDD Platform
NMR is a benchmark tool for fragment-based drug design, offering quantitative binding data and detailed structural insights on target proteins. We are excited to introduce...
Continue ReadingUpcoming EventsView All
October 15, 2025 - October 18, 2025
Beijing, China
17th International Congress of Toxicology
Learn More
